WALLINGFORD — Gaylord Specialty Healthcare announced this week that it had begun using a new technology to disinfect people’s shoes, as it takes further safety measures amid the coronavirus pandemic.
Officials said the organization was the first in New England to “implement UVZone shoe disinfection technology from Florida-based PathO3Gen Solutions as part of an ongoing effort to protect patient and staff safety amid the COVID-19 pandemic.”
The sanitation system uses “an exclusive and multi-patented combination of Ozone and UVC light” to eliminate the vast majority of pathogens, including any “coronavirus residue on footwear in eight seconds,” Gaylord officials said.
It was paid for through a $35,000 grant from The Greater New Haven COVID-19 Community Fund, a joint effort from the Community Foundation for Greater New Haven and the United Way, officials said.
“With the CDC recommendation that all persons disinfect shoe soles before walking out of areas with COVID-19 patients, obtaining the best form of protection for our staff and patients was a priority for Gaylord,” said Dr. Stephen Holland, chief medical officer of Gaylord Specialty Healthcare. “We are appreciative to the Greater New Haven COVID-19 Community Fund for making this a reality.”
In the announcement, PathO3Gen Solutions said it was pleased to see its product put to use.
“The goal of PathO3Gen Solutions is to prevent infections and save lives by creating cleaner and safer environments. There is nothing more rewarding for us than seeing our UVZone shoe disinfection technology on the ground, when and where it really matters the most,” said Scott Beal, chief operating officer of PathO3Gen Solutions.